1 обзор по теме возможности нейротрансплантации для улучшения качества и увеличения продолжительности жизни
 Скачать 0.69 Mb.
|
|
2012. № 153 (1). P. 157–162. Mizuno H. The potential for treatment of skeletal muscle disorders with adipose-derived stem cells // Curr. Stem Cell Res. Ther. 2010. № 5 (2). P. 133–136. Moore K.E., Mills J.F., Thornton M.M. Alternative sources of adult stem cells: a possible solution to the embryonic stem cell debate // Gend. Med. 2006. № 3 (3). P. 161–168. Muguruma K., Sasai Y. In vitro recapitulation of neural development using embryonic stem cells: from neurogenesis to histogenesis // Dev. Growth Differ. 2012. № 54 (3). P. 349– 357. Pakzaban P., Isacson O. Neural xenotransplantation: reconstruction of neuronal circuitry across species barriers // Neuroscience. 1994. № 62 (3). P. 989–1001. Pang Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., Citri A., Sebastiano V., Marro S., Südhof T.C., Wernig M. Induction of human neuronal cells by defined transcription factors // Nature. 2011. № 476 (7359). P. 220–223. Paspala S.A., Murthy T.V., Mahaboob V.S., Habeeb M.A. Pluripotent stem cells – a review of the current status in neural regeneration // Neurol. India. 2011. № 59 (4). P. 558–565. Petit I., Kesner N.S., Karry R., Robicsek O., Aberdam E., Müller F.J., Aberdam D., Ben- Shachar D. Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders // Stem Cell Res. 2012. № 8 (1). P. 134–140. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., Apostolou E., Stadtfeld M., Li Y., Shioda T., Natesan S., Wagers A.J., Melnick A., Evans T., Hochedlinger K. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells // Nat. Biotechnol. 2010. № 28 (8). P. 848–855. 34 Reekmans K., Praet J., Daans J., Reumers V., Pauwels P., Van der Linden A., Berneman Z.N., Ponsaerts P. Current challenges for the advancement of neural stem cell biology and transplantation research // Stem Cell Rev. 2012. № 8 (1). P. 262–278. Rietze R.L., Reynolds B.A. Neural stem cell isolation and characterization // Methods Enzymol. 2006. № 419. P. 3–23. Ring K.L., Tong L.M., Balestra M.E., Javier R., Andrews-Zwilling Y., Li G., Walker D., Zhang W.R., Kreitzer A.C., Huang Y. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor // Cell Stem Cell. 2012. № 11 (1). P. 100–109. Rochkind S., Ouaknine G.E. New trend in neuroscience: Low-power laser effect on peripheral and central nervous system (basic science, preclinical and clinical studies) // Neurological Research. 1992. № 14 (1). P. 2–11. Rosser A.E., Zietlow R., Dunnett S.B. Stem cell transplantation for neurodegenerative diseases // Curr. Opin. Neurol. 2007. № 20 (6). P. 688–692. Ruff C.A., Fehlings M.G. Neural stem cells in regenerative medicine: bridging the gap // Panminerva Med. 2010. № 52 (2). P. 125–147. Saburina I.N. Embryonic nervous tissue transplantation accelerates restoration of hypoxia- damaged blood-brain barrier in rats // J. Hirnforsch. 1989. № 30 (6). P. 737–745. Schulz M.K., Sorensen J.C., Tillotson G.L., Castro A.J., Zimmer J. The effect of fetal neocortical transplants on lesion-induced cerebral cortex plasticity // Cell Transplant. 1996. № 5 (2). P. 279–286. Sensebé L., Bourin P. Mesenchymal stem cells for therapeutic purposes // Transplantation. 2009. № 87 (9 Suppl). P. S49–S53. Shi X., Kang Y., Hu Q., Chen C., Yang L., Wang K., Chen L., Huang H., Zhou C. A long-term observation of olfactory ensheathing cells transplantation to repair white matter and functional recovery in a focal ischemia model in rat // Brain Res. 2010. № 1317. P. 257– 267. Shruster A., Melamed E., Offen D. Neurogenesis in the aged and neurodegenerative brain // Apoptosis. 2010. № 15 (11). P. 1415–1421. Shyu W.C., Liu D.D., Lin S.Z., Li W.W., Su C.Y., Chang Y.C., Wang H.J., Wang H.W., Tsai C.H., Li H. Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke // J. Clin. Invest. 2008. № 118 (7). P. 2482–2495. Sprick U., Hasenohrl R.U., Krauth J., Klapdor K., Huston J.P. Effects of chronic substance P treatment and intracranial fetal grafts on learning after hippocampal kainic acid lesions // Peptides. 1996. № 17 (2). P. 275–285. 35 Srivastava A.S., Malhotra R., Sharp J., Berggren T. Potentials of ES cell therapy in neurodegenerative diseases // Curr. Pharm. Des. 2008. № 14 (36). P. 3873–3879. Stabenfeldt S.E., Irons H.R., Laplaca M.C. Stem cells and bioactive scaffolds as a treatment for traumatic brain injury // Curr. Stem Cell Res. Ther. 2011. № 6 (3). P. 208–220. Su Z., He C. Olfactory ensheathing cells: biology in neural development and regeneration // Prog. Neurobiol. 2010. № 92 (4). P. 517–532. Sugaya K. Neuroreplacement therapy and stem cell biology under disease conditions // Cell Mol Life Sci. 2003. № 60 (9). P. 1891–1902. Tate C.C., Shear D.A., Tate M.C., Archer D.R., Stein D.G., LaPlaca M.C. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain // J. Tissue Eng. Regen. Med. 2009. № 3 (3). P. 208–217. Taupin P. Adult neurogenesis in the mammalian central nervous system: functionality and potential clinical interest // Med. Sci. Monit. 2005. № 11 (7). P. RA247–252. Thier M., Wörsdörfer P., Lakes Y.B., Gorris R., Herms S., Opitz T., Seiferling D., Quandel T., Hoffmann P., Nöthen M.M., Brüstle O., Edenhofer F. Direct conversion of fibroblasts into stably expandable neural stem cells // Cell Stem Cell. 2012. № 10 (4). P. 473–479. Truwit C.L., Denaro C.P., Lake J.R., DeMarco T. MR imaging of reversible cyclosporin A- induced neurotoxicity // AJNR. Am. J. Neuroradiol. 1991. № 12 (4). P. 651–659. Turner D.A., Kearney W. Scientific and ethical concerns in neural fetal tissue transplantation // Neurosurgery. 1993. № 33 (6). P. 1031–1037. Tutter A.V., Baltus G.A., Kadam S. Embryonic stem cells: a great hope for a new era of medicine // Curr. Opin. Drug Discov. Devel. 2006. № 9 (2). P. 169–175. Victorov I.V., Lyjin A.A. Intracerebral transplantation of cultured glio neuronal aggregates and fetal brain tissue fragments // Proc. Indian Nath. Sci. Acad. 1990. № 56 (1). P. 73–84. Webber A., Hirose R., Vincenti F. Novel strategies in immunosuppression: issues in perspective // Transplantation. 2011. № 91 (10). P. 1057–1064. Winder H., Brundin P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis // Brain Res. 1988. № 472 (3). P. 287–324. Ying C., Hu W., Cheng B., Zheng X., Li S. Neural Differentiation of Rat Adipose-Derived Stem Cells in Vitro // Cell Mol. Neurobiol. 2012. May 9. [Epub ahead of print]. Zeng X., Rao M.S. Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement // Neuroscience. 2007. № 145 (4). P. 1348– 1358. 36 Zou Z., Jiang X., Zhang W., Zhou Y., Ke Y., Zhang S., Xu R. Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease – a rat model study // Brain Res. 2010. № 1346. P. 279–286. |